Skip to main content

Table 1 Clinical characteristics of the patients

From: ATF5 regulates tubulointerstitial injury in diabetic kidney disease via mitochondrial unfolded protein response

 

Control (n = 10)

DN (n = 10)

Age (y)

33.0 ± 10.4

47.5 ± 6.9

Sex (male/female)

4/6

5/5

Duration (y)

–

13.1 ± 2.9

BMI (kg/m2)

22.9 ± 2.6

24.8 ± 3.5

Glucose (mmol/L)

4..2 ± 0.5

7.9 ± 5.3*

Hb (g/L)

32.4 ±  14.3

8.3 ± 1.2

HbA1c (%)

4.7 ± 0.5

7.9 ± 0.5*

Total cholesterol (mmol/L)

4.5 ± 0.9

6.2 ± 0.7

Triglyceride (mmol/L)

1.6 ± 0.5

2.5 ± 0.6

Albumin (g/L)

39.1 ± 4.6

25.2 ± 3.1*

Scr (μmol/L)

66.7 ± 9.3

137.1 ± 17.5*

BUN (mmol/L)

5.1 ± 0.5

9.1 ± 2.3*

UA (μmol /L)

289.3 ± 19.5

365 ± 42.1*

24-h urine protein (g/d)

0.6 ± 0.5

5.1 ± 1.3*

SBP (mm Hg)

108 ± 6.7

119 ± 8.2

DBP (mm Hg)

69 ± 8.5

82 ± 11.3

  1. BMI body mass index, BUN blood urea nitrogen, DBP diastolic blood pressure, Hb hemoglobin, HbA1c glycosylated hemoglobin, SBP systolic blood pressure, Scr serum creatinine, UA uric acid. *p < 0.5 vs control; values are Mean ± SD